Picard Medical: FDA-Approved Artificial Heart, But Ramp-Up Remains Uncertain

PMI’s FDA-approved SynCardia STAH is promising, but adoption and revenues lag; cash burn and dilution weigh. Read the full ...
The Caledonian-Record

Imbria Pharmaceuticals Announces Publication of IMPROVE-DiCE Phase 2a Data in Circulation,

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart failure with preserved ejection fraction (HFpEF) ...
The Caledonian-Record

Newton Golf Expects to Report Record 2025 Revenue Results, Exceeding Prior Guidance

During 2025, Newton Golf executed decisively against its long-term strategy, expecting to report full-year revenue that exceeded its previously issued guidance range of $7.0 million to $7.5 million, ...